abstract |
The compounds and salts of the present invention inhibit kinases, particularly the epidermal growth factor receptor family (EGFR, erbB-2, erbB-4) and clinically important "gatekeeper" mutants of these kinases, and are useful in the treatment of Or to improve abnormal cell proliferative disorders, such as cancer. |